Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination product containing xylitol, calcium, and phosphate, typically formulated as a lozenge or chewing gum for oral health. Xylitol is a sugar alcohol that inhibits the growth of cariogenic bacteria such as Streptococcus mutans by being non-fermentable and reducing acid production in dental plaque. Calcium and phosphate ions support remineralization of tooth enamel by providing essential minerals needed to repair early carious lesions. The combination aims to increase salivary pH, buffer acids in the mouth, stimulate saliva flow, and enhance remineralization processes to prevent dental caries and erosion[1][2][3][5]. Such products are especially considered for individuals at risk of dental caries or with reduced salivary flow.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xylitol + calcium + phosphate.